Global University Venturing will reveal the winners of this year's awards at the gala dinner as part of the GCV Symposium on November 3.

Global University Venturing’s editorial board is excited to present the shortlist for this year’s GUV Awards. The nominations are listed in alphabetical order and were selected by the editorial board based on the past 12 months.

The winners will be revealed at a gala dinner in the crypt of St Paul’s Cathedral in London, UK on November 3 as part of the GCV Symposium. We will feature in-depth articles about each winner in a supplement to our October magazine issue.

Tickets to the conference are available at a promotional rate until October 6, with a reduced rate for virtual attendance only. Guests can also choose to attend the dinner only. All bookings can be made here.

Tech Transfer Office of the Year

  • Axelys
  • Edinburgh Innovations
  • University of Manchester Innovation Factory
  • UnternehmerTUM
  • University of Michigan Office of Technology Transfer

Personality of the Year

  • Alexis Dormandy, Oxford Sciences Innovation
  • Brian McCaul, Qubis
  • Sara Wallin, Chalmers Ventures
  • Markus Wanko, IST Austria
  • Moray Wright, Parkwalk Advisors

Fundraising of the Year

  • Keio Innovation Initiative
  • Main Sequence Ventures
  • The Engine
  • University Bridge Fund
  • V-Bio Ventures

Investment Unit of the Year

  • Cambridge Innovation Capital
  • Osage University Partners
  • The Engine
  • Uniseed
  • UTokyo Innovation Platform

CVC Investment in a Spinout of the Year

  • Artios, $153m series C (M Ventures, Novartis Venture Fund and Pfizer Ventures)
  • Century Therapeutics, $160m series C (Leaps by Bayer)
  • Deep Genomics, $180m series C (SoftBank Vision Fund 2, Alexandria Venture Investments)
  • Prime Medicine, $200m series B (GV)
  • PsiQuantum, $450m series D (Microsoft’s M12)

Deal of the Year

  • Centessa Pharmaceuticals, $250m series A
  • Exscientia, $225m series D
  • Form Energy, $240m series D
  • Graphcore, $222m series E
  • Paige, $100m series C

Technology of the Year

  • Atalanta Therapeutics, University of Massachusetts
  • DNAnudge, Imperial College London
  • Ensoma, University of Washington and Fred Hutchinson Cancer Research Center
  • Nuvectis, Institute of Cancer Research
  • Stablix Therapeutics, Columbia University

Exit of the Year

  • Base Genomics, University of Oxford ($410m acquisition by Exact Sciences)
  • Evolv, Duke University (reverse merger at $1.25bn valuation)
  • Farapulse, University of Iowa ($295m acquisition by Boston Scientific)
  • Oatly, Lund University ($1.43bn IPO)
  • Sana Biotechnology, Harvard University ($588m IPO)

Lifetime Achievement Award 

This award is in recognition of a person whose career and dedication to technology transfer have had a profound impact on the sector. The recipient will be announced publicly on the night.